PREVALENCE OF COMPLICATIONS RELATED WITH TRANSULNAR APPROACH IN PATIENTS UNDERGOING ELECTIVE PCI INTERVENTIONS
Main Article Content
Keywords
transulnar approach, percutaneous coronary intervention, complications, bleeding, myocardial injury, risk assessment
Abstract
Introduction: This procedure has evolved to be a popular criterion in elective percutaneous coronary intervention (PCI) thus providing a reliable approach to managing stable coronary artery disease. However, it remains a concern to establish the frequency and the factors that determine complications that are linked with this strategy.
Objectives: To assess the rate of adverse outcomes evolving from the transulnar approach in this population of patients who underwent elective PCI and to determine the factors which affect it.
Materials and Methods: This work was conducted in the Fatima Jinnah Medical University/ Sir Ganga Ram Hospital, Lahore, Pakistan for the six month duration of this cross-sectional study. Patient records of three hundred patients admitted for elective PCI were used in the study. Both demographic and clinical data and procedural data were recorded and major clinical events were defined as bleeding, myocardial injury and vascular complications.
Results: Of 300 patients, 23% had complications, while 12% had bleeding and 8% had myocardial injury. Hemodynamic instability, advance age, raised inflammatory markers and increased clotting time were highly significant to adverse occasions.
Conclusion: The concept of transulnar approach in elective PCI is feasible but requires certain measures to be implemented for the optimization of procedural results
References
2. Ramotowski, B., Lewandowski, P., Słomski, T., Maciejewski, P. and Budaj, A., 2024. Platelet reactivity and activated clotting time predict hemorrhagic site complications in patients with chronic coronary syndromes undergoing percutaneous coronary interventions. Coronary Artery Disease, 35(4), pp.292-298.
3. Silvain, J., Zeitouni, M., Paradies, V., Zheng, H.L., Ndrepepa, G., Cavallini, C., Feldman, D.N., Sharma, S.K., Mehilli, J., Gili, S. and Barbato, E., 2021. Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data. European heart journal, 42(4), pp.323-334.
4. Zhou, Y., Chen, Z., Ma, J., Chen, A., Lu, D., Wu, Y., Ren, D., Zhang, C., Dai, C., Zhang, Y. and Qian, J., 2020. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention. Journal of cardiology, 76(3), pp.309-316.
5. Mayer, K., Hein-Rothweiler, R., Schüpke, S., Janisch, M., Bernlochner, I., Ndrepepa, G., Sibbing, D., Gori, T., Borst, O., Holdenrieder, S. and Kupka, D., 2021. Efficacy and safety of revacept, a novel lesion-directed competitive antagonist to platelet glycoprotein VI, in patients undergoing elective percutaneous coronary intervention for stable ischemic heart disease: the randomized, double-blind, placebo-controlled ISAR-PLASTER phase 2 trial. Jama Cardiology, 6(7), pp.753-761.
6. Parikh, P.B., Bhatt, D.L., Bhasin, V., Anker, S.D., Skopicki, H.A., Claessen, B.E., Fonarow, G.C., Hernandez, A.F., Mehran, R., Petrie, M.C. and Butler, J., 2021. Impact of percutaneous coronary intervention on outcomes in patients with heart failure: JACC state-of-the-art review. Journal of the American College of Cardiology, 77(19), pp.2432-2447.
7. Waldo, S.W., Glorioso, T.J., Barón, A.E., Plomondon, M.E., Valle, J.A., Schofield, R. and Ho, P.M., 2020. Outcomes among patients undergoing elective percutaneous coronary intervention at Veterans Affairs and community care hospitals. Journal of the American College of Cardiology, 76(9), pp.1112-1116.
8. Keskin, G., Khalil, E. and Uysal, A., 2021, January. Should we postpone elective cardiovascular procedures and percutaneous coronary interventions during the COVID-19 pandemic?. In The Heart Surgery Forum (Vol. 24, No. 1, pp. E022-E030).
9. Saxon, J.T., Chan, P.S., Tran, A.T., Angraal, S., Jones, P.G., Grantham, J.A. and Spertus, J.A., 2020. Comparison of patient-reported vs physician-estimated angina in patients undergoing elective and urgent percutaneous coronary intervention. JAMA Network Open, 3(6), pp.e207406-e207406.
10. Chacko, L., P. Howard, J., Rajkumar, C., Nowbar, A.N., Kane, C., Mahdi, D., Foley, M., Shun-Shin, M., Cole, G., Sen, S. and Al-Lamee, R., 2020. Effects of percutaneous coronary intervention on death and myocardial infarction stratified by stable and unstable coronary artery disease: a meta-analysis of randomized controlled trials. Circulation: Cardiovascular Quality and Outcomes, 13(2), p.e006363.
11. Galli, M., Benenati, S., Capodanno, D., Franchi, F., Rollini, F., D'Amario, D., Porto, I. and Angiolillo, D.J., 2021. Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. The Lancet, 397(10283), pp.1470-1483.
12. Yang, J.X., Stevenson, M.J., Valsdottir, L., Ho, K., Spertus, J.A., Yeh, R.W. and Strom, J.B., 2020. Association between procedure appropriateness and patient-reported outcomes after percutaneous coronary intervention. Heart, 106(6), pp.441-446.
13. Nichita-Brendea, M.T., Popescu, M.I., Popa, V. and Carmen, P.C.D., 2021. A clinical trial comparing complete revascularization at the time of primary percutaneous coronary intervention versus during the index hospital admission in patients with multi-vessel coronary artery disease and ST-elevation myocardial infarction uncomplicated by cardiogenic shock. Anatolian journal of cardiology, 25(11), p.781.
14. Zhao, L., Li, Y., Xu, T., Luan, Y., Lv, Q., Wang, Y., Lv, X., Fu, G. and Zhang, W., 2020. Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study. Journal of Thoracic Disease, 12(10), p.5398.
15. Sun, L.Y., Gaudino, M., Chen, R.J., Eddeen, A.B. and Ruel, M., 2020. Long-term outcomes in patients with severely reduced left ventricular ejection fraction undergoing percutaneous coronary intervention vs coronary artery bypass grafting. JAMA cardiology, 5(6), pp.631-641.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Syed Muhammad Shahkar Ali
MBBS, MD Psychiatry, Department of Psychiatry and Behavioural Sciences, Mufti Mehmood Memorial Teaching Hospital, KPK, Dera Ismail Khan, Pakistan
Dr Muhammad Suleman Khan
M. D & Assistant Professor Cardiology, Fatima Jinnah Medical University/ Sir Ganga Ram Hospital, Lahore, Pakistan
Dr Muhammad Saleem
Assistant Professor of Cardiology, Department of Cardiology, Sahiwal Teaching Hospital/Sahiwal Medical College Sahiwal, Pakistan
Dr Muhammad Afzal Abbasi
Assistant Professor, Department of Cardiology, Farooq Teaching Hospital Rawalpindi Branch, Pakistan
Hussain Ahmad
Assistant Professor and Head, Department of Psychiatry MMMTH/ Gomal Medical College Dera Ismail Khan, Pakistan
Dr Muniba Saeed
Senior Registrar, Cardiac Centre.PIMS, Pakistan